Moe Toyoshima, Daiki Ikarashi, Hiroyuki Tsuboi, Makoto Moriwaka, Shinji Tamada, Tomohiko Matsuura, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Ryo Takata, et al. [A Case of Metastatic Renal Cell Carcinoma with Arthritis and Colitis Due to Immune-Related Adverse Events During Ipilimumab-Nivolumab Combination Therapy]. Hinyokika kiyo. Acta urologica Japonica. 2023. 69. 8. 227-232
Ei Shiomi, Renpei Kato, Mitugu Kanehira, Ryo Takata, Jun Sugimura, Yasuyuki Nakamura, Takashi Ujiie, Takaya Abe, Wataru Obara. Cribriform pattern in prostate tissues: Predictor for intraductal carcinoma of the prostate based on biopsy and radical prostatectomy pathology. BJUI compass. 2023. 4. 3. 339-345
Shinji Tamada, Daiki Ikarashi, Naoki Yanagawa, Moe Toyoshima, Kenta Takahashi, Tomohiko Matsuura, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Ryo Takata, et al. Metastatic bladder cancer forming a sigmoidorectal fistula after enfortumab vedotin therapy: a case report. Frontiers in oncology. 2023. 13. 1274494-1274494
Arisa Machida, Daiki Ikarashi, Naoki Yanagawa, Masamichi Suzuki, Tatsuya Kawamura, Kie Sekiguchi, Kenta Takahashi, Renpei Kato, Tomohiko Matsura, Shigekatsu Maekawa, et al. Pathological Complete Response to Preoperative Nivolumab Plus Cabozantinib for Renal Cell Carcinoma With Inferior Vena Cava Thrombus: A Case Report. Cancer diagnosis & prognosis. 2023. 3. 1. 124-129
Renpei Kato, Tomohiko Matsuura, Shigekatsu Maekawa, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Wataru Obara. Site-specific patterns of early response to nivolumab plus ipilimumab therapy in advanced renal cell carcinoma patients compared with tyrosine-kinase inhibitors. International immunopharmacology. 2022. 113. Pt B. 109443-109443
Yoichiro Kato, Hitoshi Zembutsu, Ryo Takata, Tomohiko Matsuura, Renpei Kato, Mitsugu Kanehira, Kazuhiro Iwasaki, Jun Sugimura, So Omori, Takaya Abe, et al. SELECTIVE NEOADJUVANT CHEMOTHERAPY BY PREDICTION SYSTEMS IMPROVES THE CHEMO-SENSITIVITY OF THE MUSCLE INVASIVE BLADDER CANCERS. JOURNAL OF UROLOGY. 2016. 195. 4. E669-E669
Daiki Ikarashi, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Misato Takayama, Akito Ito, Mitsutaka Onoda, Renpei Kato, Tomohiko Matsura, Kazuhiro Iwasaki, et al. PREOPERATIVE MEMBRANOUS URETHRAL LENGTH BECOMES PREDICT FACTOR FOR THE EARLY URINARY INCONTINENCE AFTER ROBOT ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY. JOURNAL OF UROLOGY. 2016. 195. 4. E315-E315
Ryo Takata, Takashi Nasu, Wataru Obara, Taisei Mushiroda, Michiaki Kubo, Hidewaki Nakagawa, Yusuke Nakamura, Tomoaki Fujioka. IMPACT OF POLYMORPHISMS IN ABCB1 AND NRI2 WITH DOCETAXEL RESPONSE FOR CASTRATION-RESISTANT PROSTATE CANCER. JOURNAL OF UROLOGY. 2014. 191. 4. E508-E509
Yoichiro Kato, Hitoshi Zembutsu, Ryo Takata, Kazuhiro Iwasaki, Wataru Obara, Yusuke Nakamura, Tomoaki Fujioka. A PROSPECTIVE STUDY TO EXAMINE THE AVAILABILITY OF THE PREDICTION SYSTEM OF NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER. JOURNAL OF UROLOGY. 2013. 189. 4. E589-E590
Shusuke Akamatsu, Ryo Takata, Atsushi Takahashi, Michiaki Kubo, Christopher Haiman, Brien Henderson, Tomoaki Fujioka, Tomonori Habuchi, Yusuke Nakamura, Osamu Ogawa, et al. A COMMON GENETIC VARIANTS BASED RISK PREDICTION MODEL FOR PROSTATE CANCER IS HIGHLY REPRODUCIBLE IN JAPANESE, AND COMPENSATES FOR PROSTATE SPECIFIC ANTIGEN AT GRAY-ZONE. JOURNAL OF UROLOGY. 2013. 189. 4. E916-E916
